371 related articles for article (PubMed ID: 25661236)
1. Toward individualized treatment in urologic oncology.
Rini BI
Urol Oncol; 2015 Apr; 33(4):170. PubMed ID: 25661236
[No Abstract] [Full Text] [Related]
2. Precision medicine in oncology: what is it exactly and where are we?
Le Tourneau C; Kamal M; Bièche I
Per Med; 2018 Sep; 15(5):351-353. PubMed ID: 30260312
[No Abstract] [Full Text] [Related]
3. The changing landscape of urologic oncology: initiating systemic therapies, interventional skills, and clinical trials. Introduction.
Lin DW; Shore ND
Urol Oncol; 2012; 30(4 Suppl):S1. PubMed ID: 22795074
[No Abstract] [Full Text] [Related]
4. Genomic Medicine Takes the Stage, Again!
Tempero M
J Natl Compr Canc Netw; 2018 Jul; 16(7):795. PubMed ID: 30006420
[No Abstract] [Full Text] [Related]
5. [Active studies of the Working Association for Urological Oncology (AUO) in 2006].
Rexer H
Urologe A; 2006 Feb; 45(2):229-40. PubMed ID: 16440204
[No Abstract] [Full Text] [Related]
6. Clinical innovations in urologic oncology.
Williams RD
Int J Urol; 1996 Jan; 3(1 Suppl):S40. PubMed ID: 24304020
[No Abstract] [Full Text] [Related]
7. [Toward modern uro-oncology].
Villavicencio Mavrich H
Actas Urol Esp; 1996 Apr; 20(4):309-13. PubMed ID: 8801789
[No Abstract] [Full Text] [Related]
8. CRISPR-Cas13a system: a novel approach to precision oncology.
Zhang J; You Y
Cancer Biol Med; 2020 Feb; 17(1):6-8. PubMed ID: 32296572
[No Abstract] [Full Text] [Related]
9. Perspective on Precision Medicine in Oncology.
Johnson TM
Pharmacotherapy; 2017 Sep; 37(9):988-989. PubMed ID: 28632968
[TBL] [Abstract][Full Text] [Related]
10. Personalized medicine: CCO's vision, accomplishments and future plans.
Guo J; Kamel-Reid S; Rutherford M; Hart J; Melamed S; Pollett A
Healthc Q; 2015; 17 Spec No():41-3. PubMed ID: 25562133
[TBL] [Abstract][Full Text] [Related]
11. [Uro-oncology 2011].
Rübben H
Urologe A; 2011 Apr; 50(4):415. PubMed ID: 21472618
[No Abstract] [Full Text] [Related]
12. Immunoediting the cancer genome--a new approach for personalized cancer therapy?
Ribas A
Pigment Cell Melanoma Res; 2012 May; 25(3):297-8. PubMed ID: 22629569
[No Abstract] [Full Text] [Related]
13. The mice with human tumours: Growing pains for a popular cancer model.
Willyard C
Nature; 2018 Aug; 560(7717):156-157. PubMed ID: 30087485
[No Abstract] [Full Text] [Related]
14. Future directions in urological oncology.
Thompson RH
BJU Int; 2015 Apr; 115(4):499. PubMed ID: 25808707
[No Abstract] [Full Text] [Related]
15. Cancer in the Elderly: Moving the Needle Toward Evidence-Based Personalized Oncology.
Extermann M
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):718-720. PubMed ID: 28602406
[No Abstract] [Full Text] [Related]
16. Cancer genomics and clinical practice: how can we close the gap more quickly?
Konecny GE
Curr Opin Obstet Gynecol; 2017 Feb; 29(1):1-3. PubMed ID: 27941363
[No Abstract] [Full Text] [Related]
17. Precision medicine and oncology: an overview of the opportunities presented by next-generation sequencing and big data and the challenges posed to conventional drug development and regulatory approval pathways.
Doherty M; Metcalfe T; Guardino E; Peters E; Ramage L
Ann Oncol; 2016 Aug; 27(8):1644-6. PubMed ID: 27117532
[No Abstract] [Full Text] [Related]
18. Revolutionizing Precision Oncology through Collaborative Proteogenomics and Data Sharing.
Rodriguez H; Pennington SR
Cell; 2018 Apr; 173(3):535-539. PubMed ID: 29677503
[TBL] [Abstract][Full Text] [Related]
19. Systemic therapy and the urologic oncologist: a unique opportunity for the specialty to provide comprehensive care that ultimately benefits the patient.
Penson DF; Lange PH
Urol Oncol; 2012; 30(4 Suppl):S2-4. PubMed ID: 22795076
[TBL] [Abstract][Full Text] [Related]
20. Adolescent urologic oncology: current issues and future directions.
Cost NG; Cost CR; Geller JI; Defoor WR
Urol Oncol; 2014 Feb; 32(2):59-69. PubMed ID: 23141778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
